NOS3 and hypertensive disorder: Substantial evidence has shown that the treatment of hypertension was closely regulated by the activation of the Src-PI3K/Akt-eNOS signaling pathway (Hao et al., 2017) and blockage of the Ca2+ channel (Zhou et al., 2019), which were consistent with the prediction of network pharmacology.